Zenas BioPharma, Inc. Other Nonoperating Income (Expense)
Zenas BioPharma, Inc. (ZBIO) reported Other Nonoperating Income (Expense) of $16.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-13
- Zenas BioPharma, Inc. other nonoperating income (expense) for the quarter ending 2026-06-30 was $16.00K, a 92.63% decline year-over-year.
- Zenas BioPharma, Inc. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$24.00K, a 115.19% decline year-over-year.
- Zenas BioPharma, Inc. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$7.18M.
- Zenas BioPharma, Inc. other nonoperating income (expense) for the quarter ending 2025-09-30 was $1.08M, a 54.54% decline year-over-year.
- Zenas BioPharma, Inc. other nonoperating income (expense) for fiscal 2025 was $417.00K, a 106.44% increase from fiscal 2024.
- Zenas BioPharma, Inc. other nonoperating income (expense) for fiscal 2024 was $202.00K, a 67.63% decline from fiscal 2023.
- Zenas BioPharma, Inc. other nonoperating income (expense) for fiscal 2023 was $624.00K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month | Other Nonoperating Income (Expense) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-13 | -$8.00K 10-Q · filed 2026-08-13 | -$7.18M derived: sum of 3 quarters · filed 2026-08-13 | -$6.10M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$24.00K 10-Q · filed 2026-05-13 | -$7.20M derived: sum of 2 quarters · filed 2026-05-13 | -$6.12M derived: sum of 3 quarters · filed 2026-05-13 | -$5.90M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$7.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$6.09M derived: sum of 2 quarters · filed 2026-03-16 | -$5.88M derived: sum of 3 quarters · filed 2026-08-13 | $417.00K 10-K · filed 2026-03-16 | |||
| 2025-09-30 | $1.08M 10-Q · filed 2025-11-12 | $1.30M derived: sum of 2 quarters · filed 2026-08-13 | $7.59M 10-Q · filed 2025-11-12 | -$3.07M derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $217.00K 10-Q · filed 2026-08-13 | $2.96M 10-Q · filed 2025-08-12 | $376.00K 10-Q · filed 2026-08-13 | $6.51M 10-Q · filed 2025-08-12 | -$4.15M derived: sum of 3 quarters · filed 2026-08-13 | -$1.77M derived: sum of 4 quarters · filed 2026-08-13 | |
| 2025-03-31 | $158.00K 10-Q · filed 2026-05-13 | $3.55M 10-Q · filed 2025-05-15 | -$4.37M derived: sum of 2 quarters · filed 2026-05-13 | -$1.99M derived: sum of 3 quarters · filed 2026-05-13 | -$112.00K derived: sum of 4 quarters · filed 2026-05-13 | ||
| 2024-12-31 | -$4.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$2.15M derived: sum of 2 quarters · filed 2026-03-16 | -$270.00K derived: sum of 3 quarters · filed 2026-03-16 | $202.00K 10-K · filed 2026-03-16 | $8.18M 10-K · filed 2025-03-11 | ||
| 2024-09-30 | $2.38M 10-Q · filed 2025-11-12 | $4.25M derived: sum of 2 quarters · filed 2025-11-12 | $4.73M 10-Q · filed 2025-11-12 | $5.52M derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $1.88M 10-Q · filed 2025-08-12 | $2.35M 10-Q · filed 2025-08-12 | $3.14M derived: sum of 3 quarters · filed 2025-08-12 | $3.13M derived: sum of 4 quarters · filed 2025-08-12 | |||
| 2024-03-31 | $472.00K 10-Q · filed 2025-05-15 | $1.26M derived: sum of 2 quarters · filed 2025-05-15 | $1.25M derived: sum of 3 quarters · filed 2025-05-15 | ||||
| 2023-12-31 | $793.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $777.00K derived: sum of 2 quarters · filed 2025-03-11 | $624.00K 10-K · filed 2025-03-11 | ||||
| 2023-09-30 | -$16.00K 10-Q · filed 2024-11-12 | -$169.00K 10-Q · filed 2024-11-12 |